RARE — Ultragenyx Pharmaceutical Inc. stock price and chart

Share this page

RARE

$14.54-4.15%

as of close, Oct 16, 2026

☾ AH $14.54 -4.15%

Ultragenyx Pharmaceutical Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.007%US Stock Market 0.004%Russell 3000 0.004%

PeersMRNALLYMDTUNHJNJTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEE

20162019202120242026

20.040.060.080.0100.0120.0140.0160.0020.0M40.0M$14.54

2026-10-16

Price$14.54

MA20$23.28

MA50$26.04

Vol20.3M

What would $1,000 invested in RARE be worth today? →

RARE returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $14.54
YTD price return: -36.78%
YTD total return: -36.78%
Next earnings: Nov 3, 2026
Market cap: 1.4B2016-12 2.9B2026-10 1.4B-50.1% over the window
Enterprise value: 1.3B
Shares outstanding: 98.6M2016-06 39.4M2026-06 98.6M+150.0% over the window
52W low: $12.73
52W high: $39.89
From 52W high: -63.55%
From 52W low: +14.22%
52W range: 7%

Volume

Rel volume: 0.55×
30D volume: 5.3M
30D $ vol: 78.2M

Fundamentals

Sales (ttm): 717.2M2016-12 133K2026-06 717.2M+539157.1% over the window
Sales/share: $7.272016-12 $0.002026-06 $7.27+228135.1% over the window
EPS (ttm): -$5.832017-03 -$6.252026-06 -$5.83-6.7% over the window
FCF (ttm): -489M2016-06 -166M2026-06 -489M+194.5% over the window
FCF/share: -$4.962016-06 -$4.212026-06 -$4.96+17.8% over the window
Book value/share: -$2.952016-06 $11.262026-06 -$2.95-126.2% over the window
Net margin: -81.70%2016-12 -184867.7%2026-06 -81.7%-100.0% over the window
ROA: -46.36%2016-06 -42.4%2026-06 -46.4%+9.5% over the window
Current ratio: 1.732016-06 12.852026-06 1.73-86.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +17.56%2025-06-30 → 2026-06-30610.1M → 717.2M (+17.5% total)+21.19%2023-06-30 → 2026-06-30402.9M → 717.2M (+78.0% total)+14.82%2021-06-30 → 2026-06-30359.4M → 717.2M (+99.6% total)+147.19%2016-12-31 → 2026-06-30133K → 717.2M (+539157.1% total)
Shares: +2.30%2025-06-30 → 2026-06-3096.4M → 98.6M (+2.3% total)+11.31%2023-06-30 → 2026-06-3071.5M → 98.6M (+37.9% total)+7.77%2021-06-30 → 2026-06-3067.8M → 98.6M (+45.3% total)+9.60%2016-06-30 → 2026-06-3039.4M → 98.6M (+150.0% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +14.92%2025-06-30 → 2026-06-30$6.33 → $7.27 (+14.9% total)+8.88%2023-06-30 → 2026-06-30$5.64 → $7.27 (+29.1% total)+6.55%2021-06-30 → 2026-06-30$5.30 → $7.27 (+37.3% total)+125.79%2016-12-31 → 2026-06-30$0.00 → $7.27 (+228135.1% total)
Price: -57.22%2025-10-16 → 2026-10-16$33.97 → $14.54 (-57.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-26.76%2023-10-16 → 2026-10-16$37.02 → $14.54 (-60.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-28.89%2021-10-15 → 2026-10-16$80.00 → $14.54 (-81.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-13.43%2016-10-14 → 2026-10-16$61.57 → $14.54 (-76.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -57.22%2025-10-16 → 2026-10-16$33.97 → $14.54 (-57.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-26.76%2023-10-16 → 2026-10-16$37.02 → $14.54 (-60.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-28.89%2021-10-15 → 2026-10-16$80.00 → $14.54 (-81.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-13.43%2016-10-14 → 2026-10-16$61.57 → $14.54 (-76.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: -2.5×2016-12 -12.502026-10 -2.45-80.4% over the window
Fwd P/E: 22.9×
P/S (ttm)Market cap ÷ TTM revenue.: 2.0×2017-03 21563.672026-10 2.00-100.0% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: -4.9×2016-12 6.302026-10 -4.93-178.2% over the window
EV/Sales (ttm): 1.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: -34.11%2016-09 -5.7%2026-06 -14.9%+158.4% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 98.6M ÷ 96.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -2.30%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.30%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($3.5B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -2.30%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 -1.2%2026-06 0.0%-100.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.4B). Same caveat as the cash buyback yield.: 0.00%2016-09 -1.2%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S: 1st
P/B: 97th

Bar = where today’s multiple sits in RARE’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-16#

-4.15%

-6.07%

+12.89%

-51.89%

YTD

-36.78%

-57.20%

-81.83%

Financial statements

Open full RARE financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+10.48%	+0.43%
JNJ	Johnson & Johnson	-4.38%	+0.90%
ABBV	AbbVie Inc.	+8.73%	+0.71%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+6.97%	-1.29%
MRK	Merck & Co. Inc.	+0.72%	+0.52%
NVS	Novartis AG	+8.59%	+0.16%
TMO	Thermo Fisher Scientific Inc.	+6.41%	-0.93%
AMGN	Amgen Inc.	+14.92%	-0.35%

RARE — Ultragenyx Pharmaceutical Inc. price, chart and key statistics